Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin

Folia Microbiologica

Volumn 51, Issue 5, 2006, Pages 381-386

  Walencka, E ^a   Sadowska, B ^a   Rozalska S ^a   Hryniewicz, W ^b   Rozalska B ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; LYSOSTAPHIN; OXACILLIN; OXAZOLIDINONE DERIVATIVE; VANCOMYCIN;

ARTICLE; BIOFILM; CONFOCAL MICROSCOPY; DRUG COMBINATION; DRUG EFFECT; EVALUATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG THERAPY, COMBINATION; HUMANS; LYSOSTAPHIN; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; OXACILLIN; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 33751342535     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931580     Document Type: Article

References (21)

1. BAREQUET I.S., BEN SIMON G.J., SAFRIN M., OHMAN D.E., KESSLER E.: Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis. Antimicrob.Agents Chemother. 48, 1681-1687 (2004).
2. BOYLE-VAVRA S., CAREY R.B., DAUM R.S.: Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J.Antimicrob.Chemother. 48, 617-625 (2001).
3. ČERNOHORSKÁ L., VOTAVA M.: Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria. Folia Microbiol. 49, 75-78 (2004).
4. CLIMO M.W., EHLERT K., ARCHER G.L.: Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus. Antimicrob.Agents Chemother. 45, 1431-1437 (2001).
5. DAJCS J.J., THIBODEAUX B.A., GIRGIS D.O., SHAFFER M.D., DELVISCO S.M., O'CALLAGHAN R.J.: Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Invest.Ophthalmol. Visual Sci. 43, 3712-3716 (2002).
6. DRAGO L., VECCHI E.D., VALLI M., NICOLA L., GISMONDO M.R.: Effect of linezolid in comparison with that of vancomycin on glycocalyx production: in vitro study. Antimicrob.Agents Chemother. 46, 598-599 (2002).
7. EL-AZIZI M., RAO S., KANCHANAPOOM T., KHARDORI N.: In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann. Clin. Microbiol.Antimicrob. 4, 1-9 (2005).
8. FUX C.A., STOODLEY P., HALL-STOODLEY L., COSTERTON J.W.: Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev. Anti-infect.Ther. 1, 667-683 (2003).
9. GANDER S., HAYWARD K., FINCH R.: An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J.Antimicrob.Chemother. 49, 301-308 (2002).
10. GOETZ F.: Staphylococcus and biofilms. Mol.Microbiol. 43, 1367-1378 (2002).
11. HALL-STOODLEY L., COSTERTON J.W., STOODLEY P.: Bacterial biofilms: from the natural environment to infectious diseases. Nature Rev. 2, 95-106 (2004).
12. KAIRO S.K., BEDWELL J., TYLER P.C., CARTER A., CORBEL M.J.: Development of a tetrazolium salt assay for rapid determination of viability of BCG vaccines. Vaccine 17, 2423-2428 (1999).
13. KIRI N., ARCHER G., CLIMO M.W.: Combinations of lysostaphin with β-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis. Antimicrob.Agents Chemother. 46, 2017-2020 (2002).
14. LEWIS K.: Riddle of biofilm resistance. Antimicrob.Agents Chemother. 45, 999-1007 (2001).
15. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard 5th ed. M7-A5, 1-54 (2000).
16. PITTS B., HAMILTON M.A., ZELVER N., STEWART P.S.: A microtiter-plate screening method for biofilm disinfection and removal. J.Microbiol.Meth. 54, 269-276 (2003).
17. PRAKASH B., VEEREGOWDA B.M., KRISHNAPPA G.: Biofilms: a survival strategy of bacteria. Curr.Sci. 85, 1299-1307 (2003).
18. RŮŽIČKA F., HOLÁ V., VOTAVA M., TEJKALOVÁ R., HORVÁT R., HEROLDOVÁ M., WOZNICOVÁ V.: Biofilm detection and the clinical significance of Staphylococcus epidermidis isolates. Folia Microbiol. 49, 75-78 (2004).
19. WALENCKA E., SADOWSKA B., RÓŻALSKA S., HRYNIEWICZ W., RÓŻALSKA B.: Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Polish J.Microbiol. 54, 191-200 (2005).
20. WILCOX H.M.: Efficacy of linezolid versus comparator therapies in Gram-positive infections. J.Antimicrob.Ther. 51 (Suppl. S2), ii27-ii35 (2003).
21. WU J.A., KUSUMA C., MOND J.J., KOKAI-Kun J.F.: Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob.Agents Chemother. 47, 3407-3414 (2003).